Gujarat Themis strengthens on plan to manufacture & supply products to Lupin on revised terms

10 Feb 2015 Evaluate

Gujarat Themis Biosyn is currently trading at Rs. 26.05, up by 1.20 points or 4.83 % from its previous closing of Rs. 24.85 on the BSE.

The scrip opened at Rs. 23.65 and has touched a high and low of Rs. 26.05 and Rs. 23.65 respectively. So far 62681 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 5 has touched a 52 week high of Rs. 27.90 on 06-Feb-2015 and a 52 week low of Rs. 9.00 on 15-May-2014.

Last one week high and low of the scrip stood at Rs. 27.90 and Rs. 24.85 respectively. The current market cap of the company is Rs. 37.85 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 0.03% and 24.97% respectively.

Gujarat Themis Biosyn has entered into an agreement for manufacturing & supply of finish product to Lupin on revised terms during the period April 01, 2015 to March 31, 2018.

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $40 million. The company has world-wide exports to satisfied customers, having customised facility for all products.

Guj. Themis Biosyn Share Price

377.65 -9.95 (-2.57%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×